Your session is about to expire
β Back to Search
Lidocaine for Glioblastoma
Study Summary
This trial is measuring the amount and effect of lidocaine injected into patients with glioblastoma during surgery to remove their brain tumors. Lidocaine is used to relieve pain. Information from this study may help researchers develop new treatments for patients with glioblastomas.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check βYesβ for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
To what extent does Lidocaine pose a risk to human health?
"Due to the limited evidence of efficacy and safety associated with this Phase 1 trial, our team at Power has assigned Lidocaine a score of 1 on its risk assessment scale."
Could you inform me of any other studies that have been conducted on the efficacy of Lidocaine?
"Presently, 118 trials are investigating the efficacy of using Lidocaine as a treatment. 31 of those medical studies have been approved for Phase 3 and 1094 locations across the world are contributing to this research. Notably, most of these live studies occur in Calgary, Alberta."
What is the current enrollment size for this investigation?
"At this moment, this clinical trial is not enrolling patients. Its first post was on the 20th of January 2021 and its most recent edit occurred a year later. If you are seeking other studies that may be suitable for your needs, 442 trials with glioblastoma and 118 trials using lidocaine are currently accepting participants."
What medicinal purposes does Lidocaine typically serve?
"Generally, lidocaine is prescribed to manage cervical syndrome. Furthermore, this medication can be used to address minor burns, transplantation issues and even osteoporosis."
Are enrollment opportunities still available for the trial?
"According to clinicaltrials.gov, this trial is no longer seeking enrolment candidates. Initially posted on January 20th 2021 and last updated on January 21st 2022, the study has since closed its recruitment window. Despite that fact, 560 other trials are presently recruiting patients for their respective studies."
Share this study with friends
Copy Link
Messenger